Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets ...
In 2024, North America held a dominan market position, capturing more than a 36.8% share, holding USD 0.98 Billion revenue.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback